Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Gadkari
615 Dupilumab Elicits Rapid and Sustained Improvements in Itch in Adults With Moderate-To-Severe Atopic Dermatitis
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
‹
1
2
Related publications
Efficacy and Safety of Dupilumab for the Treatment of Moderate-To-Severe Atopic Dermatitis in Adults
Oncotarget
Oncology
605 Efficacy and Safety of Dupilumab in Adolescent Patients With Moderate-To-Severe Atopic Dermatitis
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Dupilumab Versus Cyclosporine for Treatment of Moderate-To-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index
Acta Dermato-Venereologica
Dermatology
Medicine
Pss43 - Dupilumab Improves Absenteeism in Moderate-To-Severe Atopic Dermatitis Patients Compared With Placebo in Phase 3 Liberty Ad Solo Studies
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Group 2 Innate Lymphoid Cells in Patients With Severe Atopic Dermatitis on Dupilumab
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Peak Pruritus Numerical Rating Scale: Psychometric Validation and Responder Definition for Assessing Itch in Moderate‐To‐Severe Atopic Dermatitis
British Journal of Dermatology
Dermatology
Medicine
673 Real-World Persistence With Dupilumab Among Adults With Atopic Dermatitis (AD)
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
After the Approval of Dupilumab for Moderate-To-Severe Atopic Dermatitis: What Is Next on the Research Agenda?
British Journal of Dermatology
Dermatology
Medicine
Dupilumab Treatment Improves Quality of Life in Adult Patients With Moderate-To-Severe Atopic Dermatitis: Results From a Randomized, Placebo-Controlled Clinical Trial
British Journal of Dermatology
Dermatology
Medicine
